中山醫學大學機構典藏 CSMUIR:Item 310902500/23533
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17918/22933 (78%)
造访人次 : 7433613      在线人数 : 163
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23533


    题名: Interleukin-1 beta-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    作者: Chang, CH;Lin, YL;Tyan, YS;Chiu, YH;Liang, YH;Chen, CP;Wu, JC;Wang, HS
    日期: 2021
    上传时间: 2022-08-05T09:38:49Z (UTC)
    出版者: PUBLIC LIBRARY SCIENCE
    ISSN: 1932-6203
    摘要: Human umbilical cord Wharton's jelly derived mesenchymal stem cells (hUCMSCs), a source of cell therapy, have received a great deal of attention due to their homing or migrating ability in response to signals emanating from damaged sites. It has been found that IL-1 beta possesses the ability to induce the expression of matrix metalloproteinase-3 (MMP-3) in bone marrow MSCs. MMP-3 is involved in cell migration in various types of cells, including glioblastoma, vascular smooth muscle, and adult neural progenitor cells. In this study, we proposed that IL-1 beta influences hUCMSCs migration involving MMP-3. The expression level of MMP-3 in IL-1 beta -induced hUCMSCs was verified using cDNA microarray analysis, quantitative real-time PCR, ELISA and Western blot. Wound-healing and trans-well assay were used to investigate the cell migration and invasion ability of IL-1 beta -treated hUCMSCs. In addition, we pre-treated hUCMSCs with interleukin-1 receptor antagonist, MMP-3 inhibitors (ALX-260-165, UK 356618), or transfected with MMP-3 siRNA to confirm the role of MMP3 in IL-1 beta -induced cell migration. Our results showed that IL-1 beta induced MMP-3 expression is related to the migration of hUCMSCs. Moreover, extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) inhibitor U0126, p38 inhibitor SB205380, JNK inhibitor SP600125 and Akt inhibitor GSK 690693 decreased IL-1 beta -induced MMP-3 mRNA and protein expression. The migration and invasion ability analyses showed that these inhibitors attenuated the IL-1 beta -induced migration and invasion ability of hUCMSCs. In conclusion, we have found that IL-1 beta induces the expression of MMP-3 through ERK1/2, JNK, p38 MAPK and Akt signaling pathways to enhance the migration of hUCMSCs. These results provide further understanding of the mechanisms in IL-1 beta -induced hUCMSCs migration to injury sites.
    URI: http://dx.doi.org/10.1371/journal.pone.0252163
    https://www.webofscience.com/wos/woscc/full-record/WOS:000664632300057
    https://ir.csmu.edu.tw:8080/handle/310902500/23533
    關聯: PLOS ONE ,2021,v16,issue 5
    显示于类别:[中山醫學大學研究成果] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML175检视/开启


    SFX Query

    在CSMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈